Azathioprine Oral Suspensions and Methods of Use
AssigneeProfessional Compounding Centers of America
InventorTsu-I Catherine Wang
Life of this patent
Estimating the term…
Loading patent…
AssigneeProfessional Compounding Centers of America
InventorTsu-I Catherine Wang
Estimating the term…
Compositions of azathioprine oral suspensions are disclosed. Disclosed azathioprine oral suspensions may be used to administer azathioprine to subjects such as children and geriatric patients that may have difficulty in swallowing solid dosage forms. The disclosed azathioprine oral suspension may be used for treating autoimmune diseases such as rheumatoid arthritis, pemphigus, Behcet's disease, autoimmune hepatitis, and inflammatory bowel disease, among others. According to an embodiment, an aqueous or non-aqueous vehicle may be used for azathioprine oral suspension. According to a different embodiment, sugar free azathioprine oral suspension may also be produced.
A pharmaceutical composition for oral administration comprising azathioprine in a concentration of about 5 mg/10 ml to about 50 mg/10 ml.
A method of treating an autoimmune disease, comprising orally delivering to a patient an effective amount of a pharmaceutical composition that comprises azathioprine.
Dependencies are inferred from the claim text.